Drug activity screening is a key step in modern drug discovery for identifying and obtaining compounds with specific biological activities. It refers to the standardized experimental process of selecting compounds with high activity toward a particular target from large libraries or newly synthesized compounds. It represents an integrated technological system that combines multiple experimental approaches.
Drug activity screening is based on experimental methods at both the molecular and cellular levels. They use microplate formats as experimental carriers, automated systems to perform procedures, sensitive and rapid detection instruments to collect data, and computer-based tools to analyze and process the results. Currently, target-based drug activity screening is widely applied in the discovery of various drugs and is an essential step in the development of new clinical therapeutics.
AnyMol is equipped with advanced automated liquid handling workstations, high-performance plate readers, and a team of skilled, experienced technicians. We can optimize experimental conditions for a wide range of biochemical and cell-based assays, and help you establish stable, user-friendly, and highly reliable experimental models. Our drug activity screening services currently cover most key targets, including G protein-coupled receptors (GPCRs), enzymatic targets, ion channels, and nuclear receptors, as well as in vitro anti-tumor screening services.
Our screening platform enables you to efficiently determine whether your compounds are ready to advance to the next stage of development.
Enzymatic Target-Based Drug Activity Screening & Analysis
We offer drug screening models covering more than 400 enzymatic, nuclear receptor, and GPCR targets, along with thousands of screening compound libraries and over 20 million structurally diverse, drug-like compounds.
GPCR Target-Based Drug Activity Screening & Analysis
We provide multiple screening methods, including cAMP, IP-1, and FLIPR assays, supported by thousands of compound libraries and over 20 million structurally diverse, drug-like compounds—capable of meeting large-scale screening demands.
Nuclear Receptor Target-Based Drug Activity Screening & Analysis
Our platform supports high-throughput screening at the scale of tens of thousands of samples, with flexible formats such as 96- and 384-well plates. We can also customize drug discovery solutions to fit your budget.
In Vitro Anti-Tumor Drug Screening
With a panel of over 110 STR-authenticated human tumor cell lines, we provide primary screening services for a wide range of compounds.